FBIO logo

Fortress Biotech (FBIO) Long Term Liabilities

Annual Total Long Term Liabilities

$81.03 M
-$35.53 M-30.48%

31 December 2023

FBIO Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$69.52 M
-$15.22 M-17.96%

30 September 2024

FBIO Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FBIO Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.5%+4.6%
3 y3 years-4.3%-24.6%
5 y5 years+23.5%-30.3%

FBIO Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-30.5%+16.4%-40.4%+4.6%
5 y5 years-30.5%+23.5%-40.4%+4.6%
alltimeall time-30.5%>+9999.0%-40.4%+9169.1%

Fortress Biotech Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$69.52 M(-18.0%)
June 2024
-
$84.74 M(+4.8%)
Mar 2024
-
$80.89 M(-0.2%)
Dec 2023
$81.03 M(-30.5%)
$81.03 M(+22.0%)
Sept 2023
-
$66.44 M(-2.4%)
June 2023
-
$68.08 M(-40.4%)
Mar 2023
-
$114.27 M(-2.0%)
Dec 2022
$116.56 M(+67.5%)
$116.56 M(+0.6%)
Sept 2022
-
$115.91 M(+4.1%)
June 2022
-
$111.33 M(+0.1%)
Mar 2022
-
$111.21 M(+59.8%)
Dec 2021
$69.58 M(-17.8%)
$69.58 M(-24.5%)
Sept 2021
-
$92.15 M(-7.2%)
June 2021
-
$99.25 M(+6.7%)
Mar 2021
-
$93.00 M(+9.9%)
Dec 2020
$84.65 M(-21.8%)
$84.65 M(+2.7%)
Sept 2020
-
$82.45 M(-13.0%)
June 2020
-
$94.75 M(-6.9%)
Mar 2020
-
$101.74 M(-6.0%)
Dec 2019
$108.27 M(+65.0%)
$108.27 M(+8.6%)
Sept 2019
-
$99.73 M(-1.3%)
June 2019
-
$101.05 M(+0.2%)
Mar 2019
-
$100.87 M(+53.7%)
Dec 2018
$65.64 M
$65.64 M(-5.6%)
Sept 2018
-
$69.51 M(-11.4%)
June 2018
-
$78.44 M(+0.3%)
DateAnnualQuarterly
Mar 2018
-
$78.20 M(+44.8%)
Dec 2017
$54.01 M(+73.1%)
$54.01 M(-2.5%)
Sept 2017
-
$55.40 M(+21.1%)
June 2017
-
$45.76 M(+39.5%)
Mar 2017
-
$32.79 M(+5.1%)
Dec 2016
$31.20 M(+31.3%)
$31.20 M(-2.5%)
Sept 2016
-
$31.99 M(+25.4%)
June 2016
-
$25.51 M(+10.1%)
Mar 2016
-
$23.17 M(-2.5%)
Dec 2015
$23.76 M(+61.3%)
$23.76 M(+1.1%)
Sept 2015
-
$23.49 M(-0.0%)
June 2015
-
$23.50 M(-3.5%)
Mar 2015
-
$24.34 M(+65.3%)
Dec 2014
$14.72 M(+81.9%)
$14.72 M(-3.1%)
Sept 2014
-
$15.19 M(+0.8%)
June 2014
-
$15.06 M(-0.1%)
Mar 2014
-
$15.07 M(+86.2%)
Dec 2013
$8.09 M(-41.5%)
$8.09 M(-18.6%)
Sept 2013
-
$9.95 M(-11.7%)
June 2013
-
$11.27 M(-10.3%)
Mar 2013
-
$12.56 M(-9.2%)
Dec 2012
$13.83 M(+1743.6%)
$13.83 M(-4.6%)
Sept 2012
-
$14.49 M(+1832.3%)
June 2012
-
$750.00 K(0.0%)
Mar 2012
-
$750.00 K(0.0%)
Dec 2011
$750.00 K
$750.00 K(-98.9%)
Sept 2011
-
$67.75 M

FAQ

  • What is Fortress Biotech annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Fortress Biotech?
  • What is Fortress Biotech annual total long term liabilities year-on-year change?
  • What is Fortress Biotech quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Fortress Biotech?
  • What is Fortress Biotech quarterly long term liabilities year-on-year change?

What is Fortress Biotech annual total long term liabilities?

The current annual total long term liabilities of FBIO is $81.03 M

What is the all time high annual total long term liabilities for Fortress Biotech?

Fortress Biotech all-time high annual total long term liabilities is $116.56 M

What is Fortress Biotech annual total long term liabilities year-on-year change?

Over the past year, FBIO annual total long term liabilities has changed by -$35.53 M (-30.48%)

What is Fortress Biotech quarterly total long term liabilities?

The current quarterly long term liabilities of FBIO is $69.52 M

What is the all time high quarterly long term liabilities for Fortress Biotech?

Fortress Biotech all-time high quarterly total long term liabilities is $116.56 M

What is Fortress Biotech quarterly long term liabilities year-on-year change?

Over the past year, FBIO quarterly total long term liabilities has changed by +$3.08 M (+4.63%)